AGL · NYSE · STOCK
Agilon Health (AGL) Stock Analysis
$83.08
52W $7.48 – $133.04
55/100
$1.37B
-5.4
2.99
Is AGL Bullish or Bearish?
Mixed.
Innellis AI committee rates Agilon Health, Inc. (AGL) Watch with a composite score of 55/100
, based on 6 analysts with 67% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +5.42 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -14.58 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- MACD histogram positive -- bullish momentum — Technical
- Low leverage (debt-to-equity 0.28) -- balance sheet can absorb a shock — Risk
Bear Case
- ROE of only -110.3% -- cheap may mean cheap for a reason — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- Bollinger bandwidth of 21.1% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
55/100
Agreement
67%
Analysts
6
Conviction
Moderate
Sector Rank
Top 68%
of 192 Healthcare peers
Value Analyst
neutral
52
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− ROE of only -110.3% -- cheap may mean cheap for a reason
Growth Analyst
bearish
38
/ 100 · Moderate confidence
Growth story is weak, decelerating, or inconsistent
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst
neutral
58
/ 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
+ Low leverage (debt-to-equity 0.28) -- balance sheet can absorb a shock
− Bollinger bandwidth of 21.1% signals elevated volatility
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 54.6 to 54.6.
- New bearish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- Risk Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
46.1
Neutral
MACD Histogram
0.596
Bullish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$51.50
Resistance
$133.00
Bollinger %B
0.41
Inside Bands
Price vs Moving Averages
EMA 9
$83.63
Below
EMA 21
$85.03
Below
EMA 50
$88.56
Below
EMA 200
$71.74
Above
Fundamental Analysis
Valuation
77
Growth
64
Profitability
0
Financial Health
62
Cash Flow
15
Valuation
P/E Ratio
-5.4×
P/B Ratio
6.05×
PEG Ratio
-1.37
Dividend Yield
0.00%
52W High
$133.04
52W Low
$7.48
Quality & Growth
ROE
-31984.1%
ROA
-3188.5%
Gross Margin
0.1%
Operating Margin
-447.9%
Revenue Growth YoY
—
Debt / Equity
0.15
AI Fundamental Assessment
P/E ratio of -5.4 (inexpensive relative to a 15-40x range); Price-to-book of 6.0x; PEG ratio of -1.4 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -319.8%; Return on assets of -31.9%; Net margin of -4.2%; Gross margin of 0.0%; Current ratio of 1.08 (tight short-term liquidity); Debt-to-equity of 0.15; Free cash flow per share is negative (-6.73); Most recent quarter beat estimates by 1101.9%; 2 consecutive earnings beats; EPS growth decelerating (+115.7% -> -42.2% QoQ); Analyst estimates rising over recent quarters
Get the Full AGL Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →